Hyper-CVAD plus ponatinib versus hyper-CVAD plus dasatinib as frontline therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A propensity score analysis (Q46196747)
Jump to navigation
Jump to search
scientific article published in August 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Hyper-CVAD plus ponatinib versus hyper-CVAD plus dasatinib as frontline therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A propensity score analysis |
scientific article published in August 2016 |
Statements
1 reference
Hyper-CVAD plus ponatinib versus hyper-CVAD plus dasatinib as frontline therapy for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A propensity score analysis (English)
1 reference
1 reference
Philadelphia chromosome
2 August 2024
1 reference
Hagop M Kantarjian
1 reference
Farhad Ravandi
1 reference
Guillermo Garcia-Manero
1 reference
Jorge E Cortes
1 reference
Naveen Pemmaraju
1 reference
Tapan M Kadia
1 reference
Marina Y Konopleva
1 reference
Elias J Jabbour
1 reference
Koji Sasaki
1 reference
Rebecca S Garris
1 reference
Naval G Daver
1 reference
Ghayas C Issa
1 reference
Susan M O'Brien
1 reference
Deborah A Thomas
1 reference
Nitin Jain
1 reference
Vicki Jeanis
1 reference
Haim G Moore
1 reference
1 August 2016
1 reference
1 reference
122
1 reference
23
1 reference
3650-3656
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference